James E. Flynn 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-09-20 6:00 pm Purchase | 2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX | James E. Flynn | 2,935,295 5.310% | 2,935,295 (New Position) | Filing |